Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
This article discusses some key infectious disease information that was released in 2022 but is unrelated to COVID-19. The literature was reviewed for sound new information relevant to internal medicine experts and subspecialists whose practice does not focus on infectious diseases. The publications mentioned are about diverse species in various patient populations.
Family Medicine/General Practice May 3rd 2023
MDLinx
Vabbing (look it up on TikTok) is the practice of putting one’s own vaginal fluid to the body in order to attract future mates or suitors. Researchers have yet to determine whether or not human pheromones exist or how they function. Vabbing can alter a user’s psychological state, improving their perceived attractiveness. According to experts, those willing to attempt vabbing may already be the type of people capable of meeting a relationship or sexual partner.
Endocrinology Advisor
In the first update in more than five years, these new guidelines review dosing recommendations for 41 antimicrobials, as applicable for patients with a BMI greater than or equal to 30 kg/m.
Endocrinology, Diabetes, Metabolism May 3rd 2023
As published in Cochrane Reviews, cranberry products reduce the risk of repeat symptomatic UTIs in women by more than a quarter. In children and individuals susceptible to UTI following medical interventions, the risk reduction is greater than 50%.
Guideline Central
Check out the updated guideline for changes prevention and treatment of VTE in a variety of cancer settings.
ACP Internist
In a randomized, double-blind, repeated crossover trial that involved almost 1,500 individuals with stage II hypertension, researchers found significant variation in individual responses to different antihypertensive treatments, particularly for lisinopril versus hydrochlorothiazide, lisinopril versus amlodipine, candesartan versus hydrochlorothiazide, and candesartan versus amlodipine. The study highlights the need for personalized antihypertensive therapy as there is substantial heterogeneity in blood pressure response to drug therapy for hypertension. The researchers recommend further studies to identify the mechanisms behind these individual differences to enable personalized antihypertensive therapy in routine clinical practice. This study’s findings underscore the importance of considering individualized treatment approaches for hypertension management to achieve optimal outcomes.
Cardiology May 3rd 2023